SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001679363-24-000004
Filing Date
2024-01-03
Accepted
2024-01-03 16:08:03
Documents
14
Period of Report
2024-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K morf-20240102.htm   iXBRL 8-K 28996
2 EX-99.1 morf-202413x8kex991.htm EX-99.1 5393
6 morphic_brandxrgb-extrasma.jpg GRAPHIC 30029
  Complete submission text file 0001679363-24-000004.txt   203266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT morf-20240102.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT morf-20240102_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT morf-20240102_pre.xml EX-101.PRE 12516
8 EXTRACTED XBRL INSTANCE DOCUMENT morf-20240102_htm.xml XML 2723
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 (781) 996-0955
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38940 | Film No.: 24506366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)